Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The cardiovascular system is the second most common target of SARS-CoV-2, which leads to severe complications, including acute myocardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagris, Marios, Theofilis, Panagiotis, Antonopoulos, Alexios S., Tsioufis, Costas, Oikonomou, Evangelos, Antoniades, Charalambos, Crea, Filippo, Kaski, Juan Carlos, Tousoulis, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234423/
https://www.ncbi.nlm.nih.gov/pubmed/34205487
http://dx.doi.org/10.3390/ijms22126607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234423/
https://www.ncbi.nlm.nih.gov/pubmed/34205487
http://dx.doi.org/10.3390/ijms22126607

Ejemplares similares